Koch Institute Symposium on Cancer Immunology and Immunotherapy
暂无分享,去创建一个
Adam Drake | Darrell J Irvine | Nikhil S. Joshi | D. Irvine | A. Drake | H. Eisen | Herman N Eisen | Gregory L Szeto | G. Szeto | Nikhil S Joshi | Eric Zhu | E. Zhu
[1] D. Irvine,et al. Synapse-directed delivery of immunomodulators using T-cell-conjugated nanoparticles. , 2012, Biomaterials.
[2] S. Steinberg,et al. Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy , 2011, Clinical Cancer Research.
[3] Bernd Hauck,et al. Chimeric antigen receptor-modified T cells for acute lymphoid leukemia. , 2013, The New England journal of medicine.
[4] Soong Ho Um,et al. Therapeutic cell engineering using surface-conjugated synthetic nanoparticles , 2010, Nature Medicine.
[5] G. Zhu,et al. Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion , 2002, Nature Medicine.
[6] D. Mooney,et al. Relationship of vaccine efficacy to the kinetics of DC and T-cell responses induced by PLG-based cancer vaccines , 2011, Biomatter.
[7] Markus G. Manz,et al. Development of a Human Adaptive Immune System in Cord Blood Cell-Transplanted Mice , 2004, Science.
[8] J Christopher Love,et al. Massively parallel detection of gene expression in single cells using subnanolitre wells. , 2010, Lab on a chip.
[9] Michel Sadelain,et al. The basic principles of chimeric antigen receptor design. , 2013, Cancer discovery.
[10] D. Greiner,et al. Humanized mice for immune system investigation: progress, promise and challenges , 2012, Nature Reviews Immunology.
[11] Drew M. Pardoll,et al. The blockade of immune checkpoints in cancer immunotherapy , 2012, Nature Reviews Cancer.
[12] Maria F. Fragoso,et al. Human CD34+ CD133+ Hematopoietic Stem Cells Cultured with Growth Factors Including Angptl5 Efficiently Engraft Adult NOD-SCID Il2rγ−/− (NSG) Mice , 2011, PloS one.
[13] S. Rosenberg,et al. T-cell therapy at the threshold , 2012, Nature Biotechnology.
[14] David L. Porter,et al. T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia , 2011, Science Translational Medicine.
[15] David J. Mooney,et al. Infection-Mimicking Materials to Program Dendritic Cells In Situ , 2008, Nature materials.
[16] J Christopher Love,et al. Multidimensional analysis of the frequencies and rates of cytokine secretion from single cells by quantitative microengraving. , 2010, Lab on a chip.
[17] Jianzhu Chen,et al. Human Fetal Hepatic Progenitor Cells Are Distinct from, but Closely Related to, Hematopoietic Stem/Progenitor Cells , 2013, Stem cells.
[18] M. Hemann,et al. Rapid generation of human B-cell lymphomas via combined expression of Myc and Bcl2 and their use as a preclinical model for biological therapies , 2012, Oncogene.
[19] Darrell J Irvine,et al. In vivo targeting of adoptively transferred T-cells with antibody- and cytokine-conjugated liposomes. , 2013, Journal of controlled release : official journal of the Controlled Release Society.
[20] A. Bagg,et al. Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia. , 2011, The New England journal of medicine.
[21] G. Zhu,et al. B7-H1 is a ubiquitous antiapoptotic receptor on cancer cells. , 2008, Blood.
[22] J Christopher Love,et al. Single-cell analysis of the dynamics and functional outcomes of interactions between human natural killer cells and target cells. , 2012, Integrative biology : quantitative biosciences from nano to macro.
[23] Steven A. Rosenberg,et al. Adoptive immunotherapy for cancer: harnessing the T cell response , 2012, Nature Reviews Immunology.
[24] R. Schreiber,et al. Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion , 2011, Science.
[25] M. Sznol,et al. Blockade of the B7-H1/PD-1 Pathway for Cancer Immunotherapy , 2011, The Yale journal of biology and medicine.
[26] I. Frazer,et al. Development of therapeutic HPV vaccines. , 2009, The Lancet. Oncology.
[27] Jianzhu Chen,et al. Engineering humanized mice for improved hematopoietic reconstitution , 2012, Cellular and Molecular Immunology.
[28] D. Pardoll,et al. A Phase I Trial of a Human Papillomavirus DNA Vaccine for HPV16+ Cervical Intraepithelial Neoplasia 2/3 , 2009, Clinical Cancer Research.
[29] J Christopher Love,et al. Development and optimization of a process for automated recovery of single cells identified by microengraving , 2010, Biotechnology progress.
[30] David C. Smith,et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. , 2012, The New England journal of medicine.
[31] Lieping Chen,et al. Inhibitory B7-family molecules in the tumour microenvironment , 2008, Nature Reviews Immunology.
[32] J. Taube,et al. Durable Cancer Regression Off-Treatment and Effective Reinduction Therapy with an Anti-PD-1 Antibody , 2012, Clinical Cancer Research.
[33] Nikolaus Rajewsky,et al. Modeling the Initiation and Progression of Human Acute Leukemia in Mice , 2022 .
[34] D. Schadendorf,et al. Improved survival with ipilimumab in patients with metastatic melanoma. , 2010, The New England journal of medicine.
[35] David J Mooney,et al. In Situ Regulation of DC Subsets and T Cells Mediates Tumor Regression in Mice , 2009, Science Translational Medicine.
[36] J. Allison,et al. Combination Immunotherapy of B16 Melanoma Using Anti–Cytotoxic T Lymphocyte–Associated Antigen 4 (Ctla-4) and Granulocyte/Macrophage Colony-Stimulating Factor (Gm-Csf)-Producing Vaccines Induces Rejection of Subcutaneous and Metastatic Tumors Accompanied by Autoimmune Depigmentation , 1999, The Journal of experimental medicine.
[37] R. Clark,et al. Human Papillomavirus 16-Associated Cervical Intraepithelial Neoplasia in Humans Excludes CD8 T Cells from Dysplastic Epithelium , 2010, The Journal of Immunology.
[38] Lloyd J. Old,et al. Adaptive immunity maintains occult cancer in an equilibrium state , 2007, Nature.
[39] Douglas A. Lauffenburger,et al. Polyfunctional responses by human T cells result from sequential release of cytokines , 2011, Proceedings of the National Academy of Sciences.
[40] J. C. Love,et al. A microengraving method for rapid selection of single cells producing antigen-specific antibodies , 2006, Nature Biotechnology.
[41] C. Rice,et al. A humanized mouse model to study hepatitis C virus infection, immune response, and liver disease. , 2011, Gastroenterology.
[42] B. Levine,et al. Perspective: Assembly line immunotherapy , 2013, Nature.
[43] M. Bility,et al. Generation of a humanized mouse model with both human immune system and liver cells to model hepatitis C virus infection and liver immunopathogenesis , 2012, Nature Protocols.
[44] E. Mardis,et al. Cancer Exome Analysis Reveals a T Cell Dependent Mechanism of Cancer Immunoediting , 2012, Nature.
[45] Qing He,et al. CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia , 2013, Science Translational Medicine.